Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor—BCX-1777

This publication has 17 references indexed in Scilit:

• Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777
  International Immunopharmacology, 2002
• Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy
  Journal of Clinical Investigation, 2002
• One-Third-the-Sites Transition-State Inhibitors for Purine Nucleoside Phosphorylase
  Biochemistry, 1998
• dNTP pools imbalance as a signal to initiate apoptosis
  Cellular and Molecular Life Sciences, 1996
• PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat bloodin vitro
  Inflammation Research, 1993
• Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers
  Analytical Biochemistry, 1989
• The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells
  Experimental Cell Research, 1989
• Allosteric regulation of calf thymus ribonucleoside diphosphate reductase
  Biochemistry, 1979
• Abnormal Purine Metabolism and Purine Overproduction in a Patient Deficient in Purine Nucleoside Phosphorylase
  New England Journal of Medicine, 1976
• NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY IN A CHILD WITH SEVERELY DEFECTIVE T-CELL IMMUNITY AND NORMAL B-CELL IMMUNITY
  The Lancet, 1975